Packaging Size | 28 tabs |
Strength | 400/100 mg |
Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Strength/Dose (in mg or ml) | sofosbuvir 400 mg and velpatasvir 100 mg |
Pack Size | 28 Tab |
Product Type | Finish Product |
Brand | Zydus |
Manufacturer | Hetero Labs |
Shelf life | 2 years |
Packaging Type | Bottles |
Country of Origin | Made in India |
Sofosbuvir With Velpatasvir is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.
Mechanism of action:Sofosbuvir With Velpatasvir is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor and velapatasvir, an NS5A replication complex inhibitor. Sofosbuvir is approved for the treatment of genotype 1, 2, 3 and 4 HCV infection with different regimens and durations dependent on the HCV genotype. Velpatasvir (formerly GS-5816) is a novel NS5A inhibitor that has potent invitro anti-HCV activity across all genotypes at the picomolar level. The combination of sofosbuvir-velpatasvir is the first once-daily single-tablet regimen with pangenotypic activity.
Dosage and Administration:Sofosbuvir With Velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.
Risk of Serious Symptomatic Bradycardia When Sofosbuvir Is Coadministered with Amiodarone and Another HCV Direct Acting Antiviral: Amiodarone is not recommended for use with Sofosbuvir With Velpatasvir due to the risk of symptomatic bradycardia, particularly in patients also taking beta blockers or with underlying cardiac comorbidities and/or with advanced liver disease. In patients without alternative, viable treatment options, cardiac monitoring is recommended. Patients should seek immediate medical evaluation if they develop signs or symptoms of bradycardia.
Risk of Reduced Therapeutic Effect Due to Concomitant Use of Sofosbuvir With Velpatasvir with P-gp Inducers and/or Moderate to Potent Inducers of CYP2B6, CYP2C8 or CYP3A4: Rifampin, St. Johns wort, and carbamazepine are not recommended for use with Sofosbuvir With Velpatasvir as they may significantly decrease sofosbuvir and/or velpatasvir plasma concentrations.
Composition | Entecavir IP 1 mg |
Treatment | HIV Infection, Hepatitis B |
Form | Tablet |
Packaging Size | 30 Tablets |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Shelf life | 2 Years |
Brand | Entekor |
Packaging Type | Bottles |
The benefits of therapy can be presented in this way
Entekor (Entecavir 1mg refers to new drugs from the group of nucleoside analogues for the treatment of chronic HBV infection. It is a carboxylic analogue of 2'-deoxyguanosine, rapidly transforming into a cell in an active form, suppressing the replication of HBV in all its three stages - initiation, elongation, termination.
Conducted studies of the efficacy of Entecavir in the treatment of patients with chronic hepatitis B showed good tolerability, a high safety profile, a higher efficacy than Lamivudine, and a lack of resistance after 2 years of administration in patients previously untreated with nucleoside analogues. The efficacy of the drug for prescribing patients resistant to Lamivudine was also demonstrated. In all of these cases, Entecavir can be considered the first-line therapy for HBV infection.
Note:
For oral use
Brand Name | IVERKAST |
Brand | IVERKAST |
Dosage | 12MG |
Strength | 12mg |
Packaging Size | 12*4 Box (48 Tablets) |
Tablets in a Strip | 4 Tablets |
Manufacturer Name | APRAZER HEALTHCARE PVT. LTD. |
Packaging Type | Strip |
Prescription Required | Yes |
Manufacturer | APRAZER HEALTHCARE PVT. LTD. |
Composition (Salts) | IVERMECTIN TABLETS USP 12MG |
Composition | IVERMECTIN TABLETS USP 12MG |
Usages | Curing Roundworm Infections |
Storage Conditions | 15 - 25 Deg C |
Ivermectin is an anti-parasite medication used to treat parasitic diseases.
Ivermectin is an FDA approved drug for use in humans to treat a variety of parasitic infections including parasitic worms, hookworm and whipworm. It may also be used as an effective treatment for a wide range of other conditions and as a treatment of onchocerciasis, intestinal strongyloidiasis and onchocerciasis or river blindness.
The antiviral activity of Ivermectin has been shown against a wide range of RNA and DNA viruses, for example, dengue, Zika, yellow fever, and others.
Strength | 400 mg |
Packaging Size | 1 x 10 Tablets |
Brand | Favikast |
Composition | Favipiravir 400 mg |
Treatment | Covid-19 |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Form | Tablet |
Shelf life | 2 Years |
Packaging Type | Box |
Packaging Size | 30 Tablets |
Brand | Tenof |
Manufacturer | Hetero Healthcare |
Composition | Tenofovir Disoproxil Fumarate IP 300 mg |
Treatment | HIV Infection, Hepatitis B |
Form | Tablet |
Shelf life | 2 Years |
Packaging Type | Bottle |
Packaging Size | 30 Tablets |
Brand | Tenvir |
Manufacturer | Cipla |
Composition | Tenofovir Disoproxil Fumarate IP 300 mg |
Treatment | HIV Infection, Hepatitis B |
Form | Tablet |
Shelf life | 2 Years |
Packaging Type | Bottle |
Color | Lake Indigo Carmine & Titanium Dioxide |
Strength | 200 mg |
Packaging Size | 1X34 tablets |
Brand | Fabiflu |
Manufacturer | Glenmark Pharmaceutical |
Quantity | 34 Tab |
Quantity Unit | Strip |
Treatment | COVID-19 |
Packaging Size | Bottle |
Brand | Tenvir-AF |
Composition | Tenofovir Alafenamide 25 mg |
Treatment | HIV, Hepatitis |
Form | Tablet |
Shelf life | 2 Years |
Packaging Type | Bottle |
Color | Ferric Oxide USP-NF Red, Black Iron Oxide & Titanium Dioxide IP |
Minimum Order Quantity | 4 Box |
Packaging Size | 4 Tablets |
Brand | Valgan |
Manufacturer | Cipla Ltd |
Composition | Valganciclovir 450 mg |
Treatment | Cytomegalovirus Infection |
Packaging Type | Box |
Form | Tablet |
Treatment | Eye infection by herpes simplex virus |
Form | Tablet |
Medicine Type | Allopathic |
Packaging Size | 10 x 10 Tablets |
Brand | Cymgal |
Manufacturer | Biocon |
Packaging Type | Box |
Composition | Valganciclovir USP 450 mg |
Packaging Size | 10 Tablets |
Composition | Entecavir 0.5 mg |
Treatment | HIV Infection, Hepatitis B |
Form | Tablet |
Brand | Entavir |
Manufacturer | Cipla |
Shelf life | 2 Years |
Packaging Type | Box |
Minimum Order Quantity | 1 Stripe |
Packaging Type | 10 capsules |
Dose/Strength (ex. 1 mg or 1 ml) | 250mg |
Natclovir is an antiviral agent. It works by blocking reproduction of the CMV virus. It helps control CMV retinitis and decrease the risk of blindness.
WHAT IS THE USE OF NATCLOVIR 250 MG CAPSULES ?It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ or bone marrow transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Ganciclovir 250 mg is also used to treat people with weakened immune systems (including people with AIDS) who have CMV retinitis.
WHAT ARE THE POSSIBLE SIDE-EFFECTS OF NATCLOVIR 250 MG CAPSULES ?Diarrhea, upset stomach, dizziness, drowsiness, unsteadiness, shaking (tremors), or pain/redness/irritation at the injection site may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Tell your doctor right away if any of these unlikely but serious side effects occur: mental/mood changes (such as confusion, hallucinations), signs of kidney problems (such as change in the amount of urine), seizures.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.